NFKB1 and cancer: We and others have shown that constitutive activation of NF-κB1/RelA is among the important factors that control expression of genes that regulate cellular proliferation, apoptosis, angiogenesis, immune and proinflammatory responses, and therapeutic resistance in HNSCCs [21-26] and other cancers [27-29].